Visus Therapeutics: Funding, Investors & Team (Oct 2026)
Visus Therapeutics is a clinical-stage company developing innovative medicines to improve the vision for people around the world.
Visus Therapeutics has raised $56.0M across 2 funding rounds on record, the most recent a Debt Financing of $20.0M announced in Aug 2021.
That round is above the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Visus Therapeutics Company Profile and Key Stats
Latest funding round on record: Aug 2021.
Visus Therapeutics Funding Rounds
Visus Therapeutics raised $36.0M in a Series A announced in Mar 2021.
5 months later, a Debt Financing of $20.0M was announced in Aug 2021.
Visus Therapeutics Founders and Leadership Team
No contact details are on record for this team yet.
Visus Therapeutics Funding Compared to Other Biotechnology Startups
Visus Therapeutics' latest round of $20.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Visus Therapeutics in Biotechnology and Seattle
Companies Similar to Visus Therapeutics
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…
Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…
Datavant is a developer of a healthcare data platform dedicated to assisting in protecting, matching, and…
Visus Therapeutics Funding FAQs
What does Visus Therapeutics do?
Visus Therapeutics is a clinical-stage company developing innovative medicines to improve the vision for people around the world.
How much funding has Visus Therapeutics raised?
Visus Therapeutics has raised $56.0M across 2 rounds on record. The most recent is a Debt Financing of $20.0M announced in Aug 2021.
When did Visus Therapeutics last raise funding?
Visus Therapeutics' most recent funding round on record is a Debt Financing of $20.0M, announced in Aug 2021.
Who is the CEO of Visus Therapeutics?
Ben Bergo is listed as CEO at Visus Therapeutics.
Where is Visus Therapeutics headquartered?
Visus Therapeutics is based in Seattle, Washington, United States.
How many employees does Visus Therapeutics have?
Visus Therapeutics is in the 11-50 employee band.
How does Visus Therapeutics' funding compare to other Biotechnology startups?
Visus Therapeutics' latest round of $20.0M is above the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Visus Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Visus Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.